Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
Titel:
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
Auteur:
Verma, Subodh Dhingra, Nitish K Butler, Javed Anker, Stefan D Ferreira, Joao Pedro Filippatos, Gerasimos Januzzi, James L Lam, Carolyn S P Sattar, Naveed Peil, Barbara Nordaby, Matias Brueckmann, Martina Pocock, Stuart J Zannad, Faiez Packer, Milton